rss
Heart 83:406-409 doi:10.1136/heart.83.4.406
  • Cardiovascular medicine

Treatment with epoprostenol reverts nitric oxide non-responsiveness in patients with primary pulmonary hypertension

Table 2

Short term administration of NO after continuous epoprostenol treatment

  • Mean arterial pressure, pulmonary wedge pressure, and mixed venous oxygen saturation did not change significantly after combined administration of epoprostenol and inhalation of NO, though there was a tendency for mixed venous oxygen saturation to rise after short term inhalation of NO.

  • Apm, mean arterial pressure; PCWP, pulmonary capillary wedge pressure; Svo 2, mixed venous oxygen saturation.

This Article

Latest from Education in Heart

Latest from Education in Heart

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Heart.
View free sample issue >>

Free archive
The full back archive is now available for Heart. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.